II. Epidemiology
- Rare, severe Thrombocytopenia occurring within 5-15 days of Platelet Transfusion
- More common in Multiparous women who have not previously received Platelet Transfusion
III. Pathophysiology
- Alloantibody reaction to human PlateletAntigen (HPA)-1a
- Sensitization occurs during pregnancy (or from prior Platelet Transfusion)
IV. Course
- Resolves over days to weeks
V. Differential Diagnosis
- Drug induced Thrombocytopenia
- Sepsis
-
Dilutional Thrombocytopenia
- Occurs with Massive Transfusion Protocol (e.g. 15 units pRBC in prior 24 hours) if not balanced
- Onset within 24 hours (Contrast with 5-15 days in Post-Transfusion Purpura)
VI. Management: Severe Thrombocytopenia and Bleeding Complications
- Similar management to Immune Thrombocytopenic Purpura
- Corticosteroids
- Intravenous Immunoglobulin (IV IG)
- Plasma echange may be considered
VII. Complications
- Life threatening Hemorrhage may occur
VIII. References
- Dave, Hoag, Jundoria and Lopez (2026) Crit Dec Emerg Med 40(2): 26-35